10 Years of belimumab experience: What have we learnt?
Levy, Roger A, Gonzalez-Rivera, Tania, Khamashta, Munther, Fox, Norma Lynn, Jones-Leone, Angela, Rubin, Bernie, Burriss, Susan W, Gairy, Kerry, Maurik, Andre van, Roth, David A
Published in Lupus (01.10.2021)
Published in Lupus (01.10.2021)
Get full text
Book Review
Journal Article
Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study
Ellis, Joanne, Maurik, Andre, Fortunato, Lea, Gisbert, Sophie, Chen, Keguan, Schwartz, Ann, McHugh, Simon, Want, Andrew, Santos Franco, Sara, Oliveira, Joao‐Joaquim, Price, Jeffrey, Coles, Alasdair, Brown, Kim, Su, Donggang, Craigen, Jenny L., Yang, Jiansong, Brett, Sara, Davis, Bill, Cheriyan, Joseph, Kousin‐Ezewu, Onajite, Gray, Frank, Thompson, Paul W., Fernando, Disala
Published in British journal of clinical pharmacology (01.02.2019)
Published in British journal of clinical pharmacology (01.02.2019)
Get full text
Journal Article
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients
Vlasakakis, Georgios, Napolitano, Antonella, Barnard, Ruth, Brown, Kim, Bullman, Jonathan, Inman, David, Keymeulen, Bart, Lanham, David, Leirens, Quentin, MacDonald, Alexander, Mezzalana, Enrica, Page, Kevin, Patel, Minesh, Savage, Caroline O., Zamuner, Stefano, Maurik, Andre
Published in British journal of clinical pharmacology (01.04.2019)
Published in British journal of clinical pharmacology (01.04.2019)
Get full text
Journal Article
Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy
Maurik, Andre van, Herber, Manuela, Wood, Kathryn J, Jones, Nick D
Published in The Journal of immunology (1950) (15.11.2002)
Published in The Journal of immunology (1950) (15.11.2002)
Get full text
Journal Article
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
McClure, Mark E, Gopaluni, Seerapani, Wason, James, Henderson, Robert B, Van Maurik, Andre, Savage, Caroline C O, Pusey, Charles D, Salama, Alan D, Lyons, Paul A, Lee, Jacinta, Mynard, Kim, Jayne, David R, Jones, Rachel B
Published in Current controlled trials in cardiovascular medicine (11.03.2023)
Published in Current controlled trials in cardiovascular medicine (11.03.2023)
Get full text
Journal Article
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes
Keymeulen, Bart, van Maurik, André, Inman, Dave, Oliveira, João, McLaughlin, Rene, Gittelman, Rachel M., Roep, Bart O., Gillard, Pieter, Hilbrands, Robert, Gorus, Frans, Mathieu, Chantal, Van de Velde, Ursule, Wisniacki, Nicolas, Napolitano, Antonella
Published in Diabetologia (01.02.2021)
Published in Diabetologia (01.02.2021)
Get full text
Journal Article
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
Aranow, Cynthia, Allaart, Cornelia F, Amoura, Zahir, Bruce, Ian N, Cagnoli, Patricia C, Chatham, Walter W, Clark, Kenneth L, Furie, Richard, Groark, James, Urowitz, Murray B, van Vollenhoven, Ronald, Daniels, Mark, Fox, Norma Lynn, Gregan, Yun Irene, Henderson, Robert B, van Maurik, André, Ocran-Appiah, Josephine C, Oldham, Mary, Roth, David A, Shanahan, Don, Tak, Paul P, Teng, Yk Onno
Published in Annals of the rheumatic diseases (19.08.2024)
Published in Annals of the rheumatic diseases (19.08.2024)
Get full text
Journal Article
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome
Mariette, Xavier, Barone, Francesca, Baldini, Chiara, Bootsma, Hendrika, Clark, Kenneth L, De Vita, Salvatore, Gardner, David H, Henderson, Robert B, Herdman, Michael, Lerang, Karoline, Mistry, Prafull, Punwaney, Raj, Seror, Raphaele, Stone, John, van Daele, Paul LA, van Maurik, André, Wisniacki, Nicolas, Roth, David A, Tak, Paul Peter
Published in JCI insight (08.12.2022)
Published in JCI insight (08.12.2022)
Get full text
Journal Article
Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren’s syndrome
Jimenez-Royo, Pilar, Bombardieri, Michele, Ciurtin, Coziana, Kostapanos, Michalis, Tappuni, Anwar R, Jordan, Natasha, Saleem, Azeem, Fuller, Teresa, Port, Kathleen, Pontarini, Elena, Lucchesi, Davide, Janiczek, Robert, Galette, Paul, Searle, Graham, Patel, Neel, Kershaw, Lucy, Gray, Calum, Ratia, Nirav, van Maurik, André, de Groot, Marius, Wisniacki, Nicolas, Bergstrom, Mats, Tarzi, Ruth
Published in Rheumatology (Oxford, England) (14.05.2021)
Published in Rheumatology (Oxford, England) (14.05.2021)
Get full text
Journal Article
Induced CD8+FoxP3+ Treg Cells in Rheumatoid Arthritis Are Modulated by p38 Phosphorylation and Monocytes Expressing Membrane Tumor Necrosis Factor α and CD86
Ellis, Shawn D. P., McGovern, Jenny L., Maurik, André, Howe, David, Ehrenstein, Michael R., Notley, Clare A.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.10.2014)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.10.2014)
Get full text
Journal Article
Epigenetically quantified immune cells in salivary glands of Sjögren’s syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopathology
Blokland, Sofie L M, van Vliet-Moret, Fréderique M, Hillen, Maarten R, Pandit, Aridaman, Goldschmeding, Roel, Kruize, Aike A, Bouma, Gerben, van Maurik, André, Olek, Sven, Hoffmueller, Ulrich, van Roon, Joel A G, Radstake, Timothy R D J
Published in Rheumatology (Oxford, England) (01.02.2020)
Published in Rheumatology (Oxford, England) (01.02.2020)
Get full text
Journal Article
Differential response of regulatory and conventional CD4⁺ lymphocytes to CD3 engagement: clues to a possible mechanism of anti-CD3 action?
Li, Li, Nishio, Junko, van Maurik, André, Mathis, Diane, Benoist, Christophe
Published in The Journal of immunology (1950) (01.10.2013)
Published in The Journal of immunology (1950) (01.10.2013)
Get full text
Journal Article
A CD3-Specific Antibody Reduces Cytokine Production and Alters Phosphoprotein Profiles in Intestinal Tissues From Patients With Inflammatory Bowel Disease
Vossenkämper, Anna, Hundsrucker, Christian, Page, Kevin, van Maurik, André, Sanders, Theodore J, Stagg, Andrew J, Das, Lisa, MacDonald, Thomas T
Published in Gastroenterology (New York, N.Y. 1943) (01.07.2014)
Published in Gastroenterology (New York, N.Y. 1943) (01.07.2014)
Get full text
Journal Article
Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity
Hillen, Maarten R, Urso, Katia, Koppe, Emma, Lopes, Ana Pinheiro, Blokland, Sofie L M, Pandit, Aridaman, Slocombe, Tom, van Maurik, André, van Roon, Joel A G, Radstake, Timothy R D J
Published in Rheumatic & musculoskeletal diseases open (01.06.2020)
Published in Rheumatic & musculoskeletal diseases open (01.06.2020)
Get full text
Journal Article
Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination Strategies
Cottingham, Matthew G, van Maurik, Andre, Zago, Manola, Newton, Angela T, Anderson, Richard J, Howard, M Keith, Schneider, Jörg, Skinner, Michael A
Published in Clinical and Vaccine Immunology (01.07.2006)
Published in Clinical and Vaccine Immunology (01.07.2006)
Get full text
Journal Article
Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model
Sabarth, Nicolas, Howard, M. Keith, Savidis-Dacho, Helga, van Maurik, André, Barrett, P. Noel, Kistner, Otfried
Published in Vaccine (08.01.2010)
Published in Vaccine (08.01.2010)
Get full text
Journal Article
Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus
Arends, Eline J, Zlei, Mihaela, Tipton, Christopher M, Cotic, Jasna, Osmani, Zgjim, J de Bie, Fenna, Kamerling, Sylvia W A, van Maurik, Andre, Dimelow, Richard, Gregan, Yun Irene, Fox, Norma Lynn, Rabelink, Ton J, Roth, David A, Sanz, Ignacio, van Dongen, Jacques J M, van Kooten, Cees, Teng, Y K Onno
Published in Rheumatology (Oxford, England) (01.09.2024)
Published in Rheumatology (Oxford, England) (01.09.2024)
Get full text
Journal Article
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture
Page, Kevin R, Mezzalana, Enrica, MacDonald, Alexander J, Zamuner, Stefano, De Nicolao, Giuseppe, van Maurik, Andre
Published in The Journal of pharmacology and experimental therapeutics (01.11.2015)
Published in The Journal of pharmacology and experimental therapeutics (01.11.2015)
Get full text
Journal Article
Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination
van Maurik, André, Sabarth, Nicolas, Dacho, Helga Savidis, Brühl, Peter, Schwendinger, Michael, Crowe, Brian A, Noel Barrett, P, Kistner, Otfried, Keith Howard, M
Published in Vaccine (17.02.2010)
Published in Vaccine (17.02.2010)
Get full text
Journal Article